FDA Revises Medical Device Regulations and Human Subject Protection Requirements

September 13, 2010

Applied Clinical Trials

1980, FDA requires IRB review for NSR (non-significant risk) devices1981, FDA and Department of Health and Human Services revise regulations for human subject protection.

Related Content:

News